Berglund, Åke
Ullén, Anders
Lisyanskaya, Alla
Orlov, Sergey
Hagberg, Hans
Tholander, Bengt
Lewensohn, Rolf
Nygren, Peter
Spira, Jack
Harmenberg, Johan
Jerling, Markus
Alvfors, Carina
Ringbom, Magnus
Nordström, Eva
Söderlind, Karin
Gullbo, Joachim
Article History
Received: 17 July 2015
Accepted: 23 October 2015
First Online: 10 November 2015
Compliance with ethical standards
:
: Rolf Lewensohn, Peter Nygren, and Joachim Gullbo are cofounders and minor shareholders of OncoPeptides AB. Jack Spira was, during the conduct of this study, employed by OncoPeptides AB. Johan Harmenberg and Markus Jerling are consultants to OncoPeptides AB. Eva Nordström and Karin Söderlind are employees of OncoPeptides AB. Carina Alvfors and Magnus Ringbom are employees of Uppsala Clinical Research, conducting the study as a CRO.